TrialThe oncologist2025

Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study.

Akinobu Nakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.